Huadong Medicine is a comprehensive pharmaceuticals company.
Huadong Medicine, founded in March 1993 and headquartered in Hangzhou, is a comprehensive manufacturer and distributor of various types of antibiotics, proprietary Chinese medicines, and synthetic drugs. The founder is Lu Liang. Listed on the Shenzhen Stock Exchange on January 27, 2020, the company's major shareholders are China Grand Enterprises and Hangzhou Huadong Medicine. The direct and indirect competitors of Huadong Medicine include Hengrui Medicine, Humanwell Healthcare, Kelun Pharmaceutical.
ForLong Biotech Nets Over CNY 100 Mn in Series A
Yimei concept stocks rose and strengthened, and Aoyang health once touched the board
Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis
‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’
Jan 30, 2023 02:13 PM
Google will ask the EU supreme judge to clarify relevant laws on the issue of a fine of 2.4 billion euros.
Kailong high tech: it plans to subscribe for the shares issued by Jingsheng with a targeted amount of 999932 yuan
2022 China AI Health 30 Report
ResearchConsumer Staples, Healthcare, Technology
WIA2020 | Rising Tech Stars 2020: Global & China's 100
Power stocks warmed up in the afternoon
4. Banking and insurance institutions shall not provide trading services for non hedging purposes for enterprises
Apple IOS will add a "Digital Heritage" function to specify contacts to inherit icloud data
Financial Associated Press, October 29 - a carbon monoxide poisoning accident occurred in an ironmaking plant in Xingtai, Hebei Province. Three people died after ineffective rescue.
Lansi Technology: the decrease in the price of customers' products does not mean the decline in the price of products supplied by the company
East China medicine: the subsidiary ornidazole tablets passed the conformity evaluation of generic drugs
Qianhe flavor industry: there is no cross period adjustment cost
Dynamic Biosystems Snags Nearly CNY 100 Mn in Series A+
Dynamic Biosystems is a single cell and space multi-omics technology platform enterprise. The company focuses on exploring the huge potential in the fields of precision medicine of tumor, eugenics and fertility, and drug discovery, and is committed to promoting precision medicine to the era of single cell and space omics, helping life science and clinical medicine.
Feb 06, 2023 07:25 PM
Opportunities and Challenges Hidden in the CGT Industry in China
CGT (Cell and Gene Therapy) is a sector with high growth potential. CAR-T, as one of the main CGT currently, presents great value for both doctors and patients. This article showcases the industry pain points and opportunities faced in the CAR-T sub-sector.
Jan 17, 2023 05:48 PM
Huadong pharmaceutical receives the regulatory inquiry letter: it is required to explain the specific situation of the dispute related to the dissolution between Huadong pharmaceutical and Ningbo
Yimei concept stocks all weakened, Aoyuan Meigu closed down
The medical beauty sector is stronger again, and aimike is reaching a new high